Population-based birth-defect and risk-factor surveillance: Data from the northern Netherlands

International Journal of Risk and Safety in Medicine

Volumn 8, Issue 3, 1996, Pages 197-209

  Cornel, Martina C ^a   Erickson, J David ^b   Khoury, Muin J ^b   James, Levy M ^b   Liu, Yecai ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Anti epileptic drugs; Congenital defects; Methodology; Psycholeptic drugs; Sex hormones; Smoking; The Netherlands

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; HOMEOPATHIC AGENT; NEUROLEPTIC AGENT; OXAZEPAM; SEX HORMONE; VALPROIC ACID;

ARTICLE; CLEFT LIP; CLEFT PALATE; CLUBFOOT; CONGENITAL DISORDER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; NETHERLANDS; NEWBORN; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 0029745212     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: 10.3233/jrs-1996-8302     Document Type: Article

References (21)

1. International Clearinghouse for Birth Defects Monitoring Systems. Congenital Malformations Worldwide, Elsevier, Amsterdam, 1991.
2. A EUROCAT Working Group, Surveillance of congenital anomalies, 1980-1990, EUROCAT Report 5, EUROCAT Central Registry, Institute of Hygiene and Epidemiology, Ministry of Public Health and Environment, Brussels, 1993.
3. E. Robert and P. Guibaud, Maternal valproic acid and congenital neural tube defects, Lancet ii (1982), 937.
4. M.J. Khoury and N.A. Holtzman, On the ability of birth defects monitoring to detect new teratogens, Am. J. Epidemiol. 126 (1987), 136-143.
5. L.P. ten Kate, M.C. Cornel and H.E.K. de Walle, Monitoring of risk factor/outcome combinations: a valuable supplement to birth defect monitoring, Int. J. Risk Safety Med. 3 (1992), 129-136.
6. E. Robert, S.E. Vollsett, L. Botto, P.A.L. Lancaster, P. Merlob, P. Mastroiacovo, G. Cocchi, M. Ashizawa, S. Sakamoto and I. Orioli, Malformation surveillance and maternal drug exposure: the MADRE project, Int. J. Risk Safety Med. 6 (1994), 75-118.
7. J.D. Erickson, J. Mulinare, P.W. McClain, T.G. Fitch, L.M. James, A.B. McClearn and M.J. Adams, Vietnam Veterans' Risk for Fathering Babies with Birth Defects, Centers for Disease Control, Atlanta, 1984.
8. J.D. Erickson, Risk factors for birth defects: data from the Atlanta birth defects case-control study, Teratology 43 (1991), 41-51.
9. M.C. Lynberg and M.J. Khoury, Interaction between epidemiology and laboratory sciences in the study of birth defects: design of birth defects risk factor surveillance in Metropolitan Atlanta, J. Toxicol. Environ. Health 40 (1993), 435-444.
10. M.J. Khoury, L.M. James and J.D. Erickson, On the use of affected controls to address recall bias in case-control studies of birth defects, Teratology 49 (1994), 273-281.
11. M.C. Cornel, H.E.K. De Walle and L.P. Ten Kate, Ten years of experience with registration of congenital anomalies in the Northern Netherlands by EUROCAT. Methodology, Tijdschrift Sociale Gezondheidszorg 70 (1992), 637-644.
12. Classification of Diseases, British Paediatric Association, London, 1987.
13. L.M. James, Statistical Analysis Battery for Epidemiologic Research (SABER), Centers for Disease Control and Prevention, Atlanta, 1993 (available upon request).
14. O.S. Miettinen, Proportion of disease caused or prevented by a given exposure, trait or intervention, Am. J. Epidemiol. 99 (1974), 325-332.
15. D. Aarskog, Association between maternal intake of diazepam and oral clefts, Lancet ii (1975), 29.
16. I. Saxen and L. Saxen, Association between maternal intake of diazepam and oral clefts, Lancet ii (1975), 498.
17. M.J. Safra and G.P. Oakley, An association of cleft lip with or without cleft palate and prenatal exposure to valium, Lancet ii (1975), 478-479.
18. A. Czeizel, Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary, Reprod. Toxicol. 1 (1988), 183-188.
19. U. Bergman, G. Boethius, P.G. Swartling, D. Isacson and B. Smedby, Teratogenic effects of benzodiazepine use during pregnancy, J. Pediatr. 116 (1990), 490-491.
20. B.W. Alderman, E.R. Takahashi and M.K. LeMier, Risk indicators for talipes equinovarus in Washington State, 1987-1989, Epidemiology 2 (1991), 289-292.
21. J.G. van der Pol, H. Wolf, K. Boer, P.E. Treffers, N.J. Leschot, H.A. Hey and A. Vos, Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins, Br. J. Obstet. Gynaecol. 99 (1992), 141-143.